BioSpace News Archive

Business

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

Immix Biopharma, Inc., announced that effective , Vaishali Sanchorawala, MD, has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.

January 4, 2024
·
6 min read
Lone Star Bio

Autonomix Medical, Inc. Provides Business Overview and Highlights Upcoming Milestones

Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today provided a business overview and highlighted upcoming milestones.

January 4, 2024
·
6 min read
Genetown

Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies

Pressure BioSciences, Inc. announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships.

January 4, 2024
·
6 min read
Business

Kiyatec Appoints Eric Perreault as New CEO to Lead Strategic Expansion

Kiyatec, a leading biotechnology company specializing in 3D cell culture technology, is pleased to announce the promotion of Eric Perreault to the position of chief executive officer.

January 4, 2024
·
2 min read
Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.

January 4, 2024
·
5 min read
Genetown

Cytrellis to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cytrellis Biosystems announced today that Jason Richey, President & Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference.

January 4, 2024
·
1 min read
Job Trends

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Galapagos NV announced that it has entered into a strategic collaboration agreement with Thermo Fisher Scientific, Inc. for the decentralized manufacturing of Galapagos’ point-of-care CAR-T product candidate in the San Francisco area.

January 4, 2024
·
5 min read
Genetown

C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals

C4 Therapeutics, Inc. announced the closing of the previously announced $25 million stock purchase agreement with a wholly-owned subsidiary of Betta Pharmaceuticals Co. Ltd, a leading pharmaceutical company focusing on the development of innovative oncology therapies in China.

January 4, 2024
·
3 min read
Business

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by abnormally elevated aldosterone, announced the appointment of Minji Kim, Ph.D. as Chief Business Officer.

January 4, 2024
·
6 min read
Drug Development

Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy

Applied Therapeutics, Inc. announced the topline results of the ARISE-HF Phase 3 trial of AT-001 in patients with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.

January 4, 2024
·
9 min read